Norway
· Delayed Price · Currency is NOK Medistim ASA Statistics
Total Valuation
Medistim ASA has a market cap or net worth of NOK 3.78 billion. The enterprise value is 3.62 billion.
| Market Cap | 3.78B |
| Enterprise Value | 3.62B |
Important Dates
The next estimated earnings date is Wednesday, August 20, 2025.
| Earnings Date | Aug 20, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Medistim ASA has 18.26 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 18.26M |
| Shares Outstanding | 18.26M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 2.93% |
| Owned by Institutions (%) | 94.98% |
| Float | 12.60M |
Valuation Ratios
The trailing PE ratio is 30.85 and the forward PE ratio is 28.85.
| PE Ratio | 30.85 |
| Forward PE | 28.85 |
| PS Ratio | 6.26 |
| PB Ratio | 8.11 |
| P/TBV Ratio | 9.39 |
| P/FCF Ratio | 28.27 |
| P/OCF Ratio | 27.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.00, with an EV/FCF ratio of 27.09.
| EV / Earnings | 29.49 |
| EV / Sales | 6.00 |
| EV / EBITDA | 20.00 |
| EV / EBIT | 22.91 |
| EV / FCF | 27.09 |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.91 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.20 |
| Interest Coverage | 194.08 |
Financial Efficiency
Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.
| Return on Equity (ROE) | 27.42% |
| Return on Assets (ROA) | 17.26% |
| Return on Invested Capital (ROIC) | 21.22% |
| Return on Capital Employed (ROCE) | 31.82% |
| Revenue Per Employee | 3.92M |
| Profits Per Employee | 797,903 |
| Employee Count | 154 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 0.73 |
Taxes
In the past 12 months, Medistim ASA has paid 37.42 million in taxes.
| Income Tax | 37.42M |
| Effective Tax Rate | 23.34% |
Stock Price Statistics
The stock price has increased by +18.18% in the last 52 weeks. The beta is 1.02, so Medistim ASA's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +18.18% |
| 50-Day Moving Average | 190.24 |
| 200-Day Moving Average | 169.38 |
| Relative Strength Index (RSI) | 56.98 |
| Average Volume (20 Days) | 4,841 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medistim ASA had revenue of NOK 603.92 million and earned 122.88 million in profits. Earnings per share was 6.71.
| Revenue | 603.92M |
| Gross Profit | 484.66M |
| Operating Income | 158.18M |
| Pretax Income | 160.29M |
| Net Income | 122.88M |
| EBITDA | 172.41M |
| EBIT | 158.18M |
| Earnings Per Share (EPS) | 6.71 |
Balance Sheet
The company has 183.45 million in cash and 26.17 million in debt, giving a net cash position of 157.28 million or 8.61 per share.
| Cash & Cash Equivalents | 183.45M |
| Total Debt | 26.17M |
| Net Cash | 157.28M |
| Net Cash Per Share | 8.61 |
| Equity (Book Value) | 466.42M |
| Book Value Per Share | 25.53 |
| Working Capital | 350.01M |
Cash Flow
In the last 12 months, operating cash flow was 139.81 million and capital expenditures -6.07 million, giving a free cash flow of 133.74 million.
| Operating Cash Flow | 139.81M |
| Capital Expenditures | -6.07M |
| Free Cash Flow | 133.74M |
| FCF Per Share | 7.32 |
Margins
Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.
| Gross Margin | 80.25% |
| Operating Margin | 26.19% |
| Pretax Margin | 26.54% |
| Profit Margin | 20.35% |
| EBITDA Margin | 28.55% |
| EBIT Margin | 26.19% |
| FCF Margin | 22.15% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 2.84%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 2.84% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 89.43% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 2.89% |
| Earnings Yield | 3.25% |
| FCF Yield | 3.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |